These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 31966596

  • 1. The diagnostic and prognostic value of serum miR-206 in colorectal cancer.
    Liu X, Zheng W, Zhang X, Dong M, Sun G.
    Int J Clin Exp Pathol; 2017; 10(7):7528-7533. PubMed ID: 31966596
    [Abstract] [Full Text] [Related]

  • 2. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
    Zou G, Wang R, Wang M.
    Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of serum miR-193b in colorectal cancer.
    Xu J, Zhao J, Zhang R.
    Int J Clin Exp Pathol; 2017; 10(9):9509-9514. PubMed ID: 31966826
    [Abstract] [Full Text] [Related]

  • 4. Upregulated serum miR-675 predicts poor prognosis for colorectal cancer.
    Zhang R, Xu J, Zhao J, Liu F.
    Int J Clin Exp Pathol; 2017; 10(7):8043-8049. PubMed ID: 31966656
    [Abstract] [Full Text] [Related]

  • 5. Upregulation of serum miR-103 predicts unfavorable prognosis in patients with colorectal cancer.
    Wang DS, Zhong B, Zhang MS, Gao Y.
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4518-4523. PubMed ID: 30058684
    [Abstract] [Full Text] [Related]

  • 6. Serum miR-199a as a potential diagnostic biomarker for detection of colorectal cancer.
    Tan HY, Zheng YB, Liu J.
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8657-8663. PubMed ID: 30575906
    [Abstract] [Full Text] [Related]

  • 7. Reduced serum miR-98 predicts unfavorable clinical outcome of colorectal cancer.
    Wang YG, He Q, Guo SQ, Shi ZZ.
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8345-8353. PubMed ID: 31646564
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serum miR-372 is a Diagnostic and Prognostic Biomarker in Patients with Early Colorectal Cancer.
    Yu J, Jin L, Jiang L, Gao L, Zhou J, Hu Y, Li W, Zhi Q, Zhu X.
    Anticancer Agents Med Chem; 2016 Oct; 16(4):424-31. PubMed ID: 26179262
    [Abstract] [Full Text] [Related]

  • 15. Serum miR-663 expression and the diagnostic value in colorectal cancer.
    Wang N, Zeng L, Li Z, Zhen Y, Chen H.
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2650-2653. PubMed ID: 31240955
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prognostic implications of serum microRNA-21 in colorectal cancer.
    Menéndez P, Padilla D, Villarejo P, Palomino T, Nieto P, Menéndez JM, Rodríguez-Montes JA.
    J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
    [Abstract] [Full Text] [Related]

  • 19. The diagnostic effect of serum miR-196b as biomarker in colorectal cancer.
    Xu C, Gu L.
    Biomed Rep; 2017 Jan; 6(1):39-45. PubMed ID: 28123705
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.